Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

References for PMC Articles for PubMed (Select 18351682)

1.
2.

Kinetics of amyloid formation and membrane interaction with amyloidogenic proteins.

Murphy RM.

Biochim Biophys Acta. 2007 Aug;1768(8):1923-34. Epub 2007 Jan 3. Review.

3.
4.

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

Haass C, Selkoe DJ.

Nat Rev Mol Cell Biol. 2007 Feb;8(2):101-12. Review.

PMID:
17245412
5.

A rapid method to measure beta-amyloid induced neurotoxicity in vitro.

Patel D, Good T.

J Neurosci Methods. 2007 Mar 30;161(1):1-10. Epub 2006 Nov 2.

PMID:
17083984
6.
7.

New insights into the self-assembly of insulin amyloid fibrils: an H-D exchange FT-IR study.

Dzwolak W, Loksztejn A, Smirnovas V.

Biochemistry. 2006 Jul 4;45(26):8143-51.

PMID:
16800639
8.

Loading, stationary phase, and salt effects during hydrophobic interaction chromatography: alpha-lactalbumin is stabilized at high loadings.

Fogle JL, O'Connell JP, Fernandez EJ.

J Chromatogr A. 2006 Jul 21;1121(2):209-18. Epub 2006 May 11.

PMID:
16690064
9.

A specific amyloid-beta protein assembly in the brain impairs memory.

Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH.

Nature. 2006 Mar 16;440(7082):352-7.

PMID:
16541076
10.

Kinetic analysis of beta-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing.

Hu WP, Chang GL, Chen SJ, Kuo YM.

J Neurosci Methods. 2006 Jun 30;154(1-2):190-7. Epub 2006 Feb 2.

PMID:
16457893
11.

The solvent protection of alzheimer amyloid-beta-(1-42) fibrils as determined by solution NMR spectroscopy.

Olofsson A, Sauer-Eriksson AE, Ohman A.

J Biol Chem. 2006 Jan 6;281(1):477-83. Epub 2005 Oct 7.

12.
13.

Molecular recycling within amyloid fibrils.

Carulla N, Caddy GL, Hall DR, Zurdo J, Gairí M, Feliz M, Giralt E, Robinson CV, Dobson CM.

Nature. 2005 Jul 28;436(7050):554-8.

PMID:
16049488
14.

Structural properties of Abeta protofibrils stabilized by a small molecule.

Williams AD, Sega M, Chen M, Kheterpal I, Geva M, Berthelier V, Kaleta DT, Cook KD, Wetzel R.

Proc Natl Acad Sci U S A. 2005 May 17;102(20):7115-20. Epub 2005 May 9.

15.

Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy.

Whittemore NA, Mishra R, Kheterpal I, Williams AD, Wetzel R, Serpersu EH.

Biochemistry. 2005 Mar 22;44(11):4434-41.

PMID:
15766273
16.

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers.

Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG.

J Biol Chem. 2005 Apr 29;280(17):17294-300. Epub 2005 Feb 17.

17.

Dynamics of urokinase receptor interaction with Peptide antagonists studied by amide hydrogen exchange and mass spectrometry.

Jørgensen TJ, Gårdsvoll H, Danø K, Roepstorff P, Ploug M.

Biochemistry. 2004 Nov 30;43(47):15044-57.

PMID:
15554712
18.
19.

Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases.

Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG.

J Biol Chem. 2004 Nov 5;279(45):46363-6. Epub 2004 Sep 21.

20.

Kinetic analysis of beta-amyloid fibril elongation.

Cannon MJ, Williams AD, Wetzel R, Myszka DG.

Anal Biochem. 2004 May 1;328(1):67-75.

PMID:
15081909
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk